This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

China responds to US Section 301 probes over alleged overcapacity, forced labor

( March 13, 2026, 07:32 GMT | Official Statement) -- MLex Summary: China’s Ministry of Commerce said Friday that the US Trade Representative’s decision to launch Section 301 investigations into 16 economies, including China, over alleged “overcapacity” is a unilateral move that undermines the international trade order, and that Washington has no authority to make unilateral determinations or impose trade restrictions. In a statement, the ministry said it is also assessing a separate Section 301 probe targeting 60 economies, including China, over an alleged failure to prohibit imports made with forced labor. China urged the US to correct its “erroneous practices” and return to resolving issues through dialogue and consultation, adding that it reserves the right to take all necessary measures to defend its legitimate rights and interests.Statement follows (in Chinese)....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections